Viveve

Viveve

Viveve

Viveve develops non-surgical treatment for women who have experienced vaginallooseness and loss of physical sensation.
Founded
2005
Raised
$22.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$15,500,000
Post-IPO equity - 2016
$7,210,000
Venture capital - 2012
5AM Ventures
Team Size
1–10
Employees
the home of AI info

Is The Stock Worthy? Viveve Medical, Inc. (NASDAQ:VIVE), Minerva Neurosciences, Inc. (NASDAQ ...

$15,500,000 Post-IPO equity
MassDevice

Viveve closes $16m uplisting